JP2015509506A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015509506A5 JP2015509506A5 JP2014558931A JP2014558931A JP2015509506A5 JP 2015509506 A5 JP2015509506 A5 JP 2015509506A5 JP 2014558931 A JP2014558931 A JP 2014558931A JP 2014558931 A JP2014558931 A JP 2014558931A JP 2015509506 A5 JP2015509506 A5 JP 2015509506A5
- Authority
- JP
- Japan
- Prior art keywords
- suspension
- immunoglobulin
- precipitate
- cohn pool
- final concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261602488P | 2012-02-23 | 2012-02-23 | |
| US61/602,488 | 2012-02-23 | ||
| PCT/US2013/027681 WO2013126904A1 (en) | 2012-02-23 | 2013-02-25 | Fraction i-iv-1 precipitation of immunoglobins from plasma |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015509506A JP2015509506A (ja) | 2015-03-30 |
| JP2015509506A5 true JP2015509506A5 (enExample) | 2016-04-07 |
| JP6291423B2 JP6291423B2 (ja) | 2018-03-14 |
Family
ID=47833446
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014558931A Active JP6291423B2 (ja) | 2012-02-23 | 2013-02-25 | 血漿からの免疫グロブリンの画分ｉ−ｉｖ−１沈殿 |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US9782477B2 (enExample) |
| EP (2) | EP4119574A1 (enExample) |
| JP (1) | JP6291423B2 (enExample) |
| KR (1) | KR101930582B1 (enExample) |
| CN (1) | CN104245730B (enExample) |
| AR (1) | AR090425A1 (enExample) |
| AU (1) | AU2013203112B2 (enExample) |
| BR (1) | BR112014020602B1 (enExample) |
| CA (1) | CA2864715A1 (enExample) |
| CL (1) | CL2014002225A1 (enExample) |
| CO (1) | CO7081143A2 (enExample) |
| DK (1) | DK2817334T3 (enExample) |
| EA (1) | EA032478B1 (enExample) |
| ES (1) | ES2928954T3 (enExample) |
| HU (1) | HUE060195T2 (enExample) |
| IL (1) | IL234103B (enExample) |
| MX (2) | MX365236B (enExample) |
| MY (1) | MY167235A (enExample) |
| NZ (1) | NZ628529A (enExample) |
| PL (1) | PL2817334T3 (enExample) |
| PT (1) | PT2817334T (enExample) |
| SG (1) | SG11201405149UA (enExample) |
| SI (1) | SI2817334T1 (enExample) |
| TW (1) | TWI629283B (enExample) |
| WO (1) | WO2013126904A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013203043B2 (en) | 2013-03-15 | 2016-10-06 | Takeda Pharmaceutical Company Limited | Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs |
| CN104004091B (zh) * | 2014-06-12 | 2016-08-17 | 新疆德源生物工程有限公司 | 一种人免疫球蛋白的制备工艺 |
| CN104004090A (zh) * | 2014-06-12 | 2014-08-27 | 新疆德源生物工程有限公司 | 一种人免疫球蛋白的制备方法 |
| GB201413227D0 (en) | 2014-07-25 | 2014-09-10 | Bioproducts Lab Ltd | Process |
| EP3334441B1 (en) * | 2015-08-13 | 2021-06-16 | Kamada Ltd. | Compositions derived from cohn fraction paste and use thereof |
| US11040068B2 (en) * | 2017-04-26 | 2021-06-22 | Alkahest, Inc. | Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products |
| WO2019086463A1 (en) | 2017-10-30 | 2019-05-09 | Baxalta GmbH | Environmentally compatible detergents for inactivation of lipid-enveloped viruses |
| CA3098609A1 (en) * | 2018-05-17 | 2019-11-21 | Csl Behring Ag | Method and system of protein extraction |
| WO2021099529A1 (en) * | 2019-11-20 | 2021-05-27 | Csl Behring Ag | Method for extracting a protein from a precipitate and method for precipitating impurities |
| AU2021355325A1 (en) * | 2020-04-10 | 2022-11-03 | Plasma Technologies, Llc | Compositions and methods for simplified high efficiency isolation of proteins |
| US20220380439A1 (en) * | 2020-11-09 | 2022-12-01 | Takeda Pharmaceutical Company Limited | Purification of fviii from plasma using silicon oxide adsorption |
| CN112250757A (zh) * | 2020-11-13 | 2021-01-22 | 广东深蓝生物科技有限公司 | 一种猪血浆中蛋白质的提取纯化方法 |
| CA3203540A1 (en) * | 2020-12-28 | 2022-07-07 | Eugene ZURLO | Systems and methods for process scale isolation of immunoglobulin g |
| CN118580342B (zh) * | 2024-05-20 | 2025-02-07 | 广东丹霞生物制药有限公司 | 一种静脉注射用人免疫球蛋白制剂的制备工艺 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE348942B (enExample) | 1970-06-02 | 1972-09-18 | Statens Bakteriologiska Labor | |
| US3998946A (en) | 1975-04-23 | 1976-12-21 | The Regents Of The University Of Minnesota | Fibrinogen-free plasminogen-plasmin-free plasma and method of preparing and using same |
| US4136094A (en) | 1977-08-31 | 1979-01-23 | The Regents Of The University Of Minnesota | Preparation of intravenous human and animal gamma globulins and isolation of albumin |
| US4499073A (en) | 1981-08-24 | 1985-02-12 | Cutter Laboratories, Inc. | Intravenously injectable immune serum globulin |
| JPS5855432A (ja) * | 1981-09-29 | 1983-04-01 | Fujirebio Inc | 静脈注射用免疫グロブリンの製法 |
| DK166763C (da) | 1983-03-16 | 1993-07-12 | Immuno Ag | Immunoglobulin-g-holdig fraktion |
| US5177194A (en) | 1990-02-01 | 1993-01-05 | Baxter International, Inc. | Process for purifying immune serum globulins |
| FR2706466B1 (fr) | 1993-06-14 | 1995-08-25 | Aetsrn | Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré. |
| US6284874B1 (en) | 1994-06-17 | 2001-09-04 | Alpha Therapeutic Corporation | Process for separating α1-proteinase inhibitor from cohn fraction IV1 and IV4 paste |
| US5616693A (en) | 1996-07-01 | 1997-04-01 | Alpha Therapeutic Corporation | Process for seperating alpha-1-proteinase inhibitor from COHN IV1 +1V4 paste |
| TW491855B (en) | 1996-08-07 | 2002-06-21 | Csl Ltd | Purification of immunoglobulins |
| CA2232420A1 (en) | 1997-03-19 | 1998-09-19 | The Green Cross Corporation | Immunoglobulin preparation and preparation process thereof |
| GB9705810D0 (en) * | 1997-03-20 | 1997-05-07 | Common Services Agency | Intravenous immune globulin |
| US5886154A (en) | 1997-06-20 | 1999-03-23 | Lebing; Wytold R. | Chromatographic method for high yield purification and viral inactivation of antibodies |
| PT911037E (pt) | 1997-10-23 | 2002-12-31 | Mitsubishi Pharma Corp | Preparacao de imunoglobulina armazenavel a temperatura ambiente para injeccao intravenosa |
| SE0001128D0 (sv) | 2000-03-30 | 2000-03-30 | Amersham Pharm Biotech Ab | A method of producing IgG |
| FR2824568B1 (fr) | 2001-05-11 | 2004-04-09 | Lab Francais Du Fractionnement | Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique |
| WO2003004982A1 (en) * | 2001-07-05 | 2003-01-16 | Hamamatsu Photonics K.K. | Spectroscopic device |
| US6893639B2 (en) * | 2001-10-19 | 2005-05-17 | Hemacare Corporation | Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates |
| PL1664123T5 (pl) | 2003-09-22 | 2012-04-30 | Kamada Ltd | Wytwarzanie w dużej skali inhibitora proteinazy alfa-1 i jego zastosowanie |
| WO2005073252A1 (en) | 2004-01-30 | 2005-08-11 | Suomen Punainen Risti Veripalvelu | Process for the manufacture of virus safe immunoglobulin |
| PT1718675E (pt) | 2004-02-27 | 2013-05-21 | Octapharma Ag | Método de proporcionar uma preparação purificada de anticorpos livre de vírus |
| US7807435B2 (en) | 2005-08-11 | 2010-10-05 | Baxter International Inc. | Method for the purification of alpha-1 proteinase inhibitor (a1PI) |
| WO2008113589A1 (en) | 2007-03-20 | 2008-09-25 | Csl Behring Gmbh | Methods for industrial scale production of therapeutic complement factor h preparations from human plasma |
| BRPI1012082B1 (pt) * | 2009-05-27 | 2022-08-16 | Takeda Pharmaceutical Company Limited | Método para preparar uma composição de igg concentrada a partir de plasma |
| AT516600B1 (de) * | 2009-07-23 | 2016-07-15 | Baxter Int | Herstellung von faktor h (fh) und fh-derivaten aus plasma |
| US8772462B2 (en) * | 2010-05-26 | 2014-07-08 | Baxter International Inc. | Removal of serine proteases by treatment with finely divided silicon dioxide |
| AU2010202125B1 (en) * | 2010-05-26 | 2010-09-02 | Takeda Pharmaceutical Company Limited | A method to produce an immunoglobulin preparation with improved yield |
| CN103119058A (zh) | 2010-07-23 | 2013-05-22 | 巴克斯特国际公司 | 由血浆生产间-α-抑制蛋白(IAIP) |
-
2013
- 2013-02-23 TW TW102106384A patent/TWI629283B/zh active
- 2013-02-25 BR BR112014020602-3A patent/BR112014020602B1/pt active IP Right Grant
- 2013-02-25 CN CN201380020621.XA patent/CN104245730B/zh active Active
- 2013-02-25 DK DK13708051.1T patent/DK2817334T3/da active
- 2013-02-25 US US13/776,448 patent/US9782477B2/en active Active
- 2013-02-25 EP EP22191464.1A patent/EP4119574A1/en active Pending
- 2013-02-25 AR ARP130100566A patent/AR090425A1/es not_active Application Discontinuation
- 2013-02-25 EA EA201491564A patent/EA032478B1/ru not_active IP Right Cessation
- 2013-02-25 JP JP2014558931A patent/JP6291423B2/ja active Active
- 2013-02-25 NZ NZ628529A patent/NZ628529A/en unknown
- 2013-02-25 PT PT137080511T patent/PT2817334T/pt unknown
- 2013-02-25 PL PL13708051.1T patent/PL2817334T3/pl unknown
- 2013-02-25 SI SI201332012T patent/SI2817334T1/sl unknown
- 2013-02-25 ES ES13708051T patent/ES2928954T3/es active Active
- 2013-02-25 WO PCT/US2013/027681 patent/WO2013126904A1/en not_active Ceased
- 2013-02-25 SG SG11201405149UA patent/SG11201405149UA/en unknown
- 2013-02-25 MX MX2014010076A patent/MX365236B/es active IP Right Grant
- 2013-02-25 KR KR1020147026210A patent/KR101930582B1/ko active Active
- 2013-02-25 AU AU2013203112A patent/AU2013203112B2/en active Active
- 2013-02-25 CA CA2864715A patent/CA2864715A1/en not_active Abandoned
- 2013-02-25 EP EP13708051.1A patent/EP2817334B1/en active Active
- 2013-02-25 MY MYPI2014002439A patent/MY167235A/en unknown
- 2013-02-25 HU HUE13708051A patent/HUE060195T2/hu unknown
-
2014
- 2014-08-13 IL IL23410314A patent/IL234103B/en active IP Right Grant
- 2014-08-21 MX MX2019005999A patent/MX2019005999A/es unknown
- 2014-08-21 CL CL2014002225A patent/CL2014002225A1/es unknown
- 2014-09-23 CO CO14210313A patent/CO7081143A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015509506A5 (enExample) | ||
| TWI596107B (zh) | 單株抗體之新穎純化方法 | |
| TWI629283B (zh) | 來自血漿中的免疫球蛋白之ｉ-ｉｖ-１部分沉澱 | |
| JP2019504030A5 (enExample) | ||
| JP5704918B2 (ja) | 第ｖｉｉｉ因子およびフォンビルブラント因子の精製方法 | |
| JP2020513804A5 (enExample) | ||
| RU2016111934A (ru) | Иммуногенные композиции коронавируса ближневосточного респираторного синдрома (mers-cov) и способы | |
| EP3019600A1 (en) | Virus like particle comprising pd-1 antigen or pd-1 ligand antigen | |
| JP2013535468A5 (enExample) | ||
| JP2019504086A5 (enExample) | ||
| JP2016104000A5 (enExample) | ||
| JP2013511481A5 (enExample) | ||
| ITFI20090273A1 (it) | Nuovo processo di purificazione su scala industriale di gammaglobuline da plasma umano per uso industriale. | |
| ZA202503137B (en) | Truncated respiratory syncytial virus f protein and use thereof | |
| US20140073766A1 (en) | METHODS FOR PURIFYING IgY ANTIBODIES | |
| Halpin et al. | Recent progress in henipavirus research | |
| CN106381288B (zh) | 一种抗h3n2亚型犬流感病毒核蛋白单克隆抗体杂交瘤2d10及单克隆抗体 | |
| JP2017525752A5 (enExample) | ||
| RU2016151761A (ru) | Очищенные композиции белков ivig и kh для модулирования лимфоцитов и лечения вируса гепатита b | |
| CN109134622B (zh) | 口蹄疫病毒抗原的多步连续集成纯化方法 | |
| JP2014525745A5 (enExample) | ||
| CN104004091B (zh) | 一种人免疫球蛋白的制备工艺 | |
| CN102584943A (zh) | 一种血管平滑肌l型钙离子通道免疫原性肽段及其用途 | |
| TWI584810B (zh) | 缺乏一種以上致血栓因子的血漿製品之製備方法 | |
| US20200190166A1 (en) | Polyvalent immunotherapeutics of high specificty based on modified antibodies and a lyophilized injectable formulation highly safe and effective |